Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

  • There is currently no data for JWNG

Exercise and completion of put option

21 Oct 2020 07:00

RNS Number : 6950C
Jaywing PLC
21 October 2020
 

21 October 2020

Jaywing plc ("Jaywing")

 ("Jaywing", "the Company" or "the Group")

Exercise and completion of put option in respect of Massive Group Pty Ltd (trading as Jaywing Australia)

Jaywing plc (AIM: JWNG), the UK agency specialising in data science, announces that the two directors of Massive Group Pty Ltd ("Massive Group") in Australia have exercised their put option in relation to the 25% of the shares in Massive Group held by entities controlled by the two directors, and which were not already owned by Jaywing. The purchase of these shares has been completed today, and Jaywing now owns 100% of the shares in Massive Group, which has traded as Jaywing Australia since 2017.

Jaywing and Massive Group Ltd entered into an Agreement on 7 July 2016, whereby Jaywing acquired 75% of the shares of Massive Group, with the remaining 25% subject to a Put and Call Option from July 2020. This 25% stake has now been acquired by Jaywing for a consideration of $4.0m (c.£2.2m), comprising $3.0m (c.£1.66m) immediately, followed by a series of monthly payments totalling $1.0m (c.£0.54m) between now and 30 June 2021. The total consideration for the purchase of the 100% interest in Massive Group is $9.5m (£5.4m).

Massive Group's business has grown strongly since 2016 and has more than doubled its EBITDA. This has enabled approximately 93% of the total consideration for the put option to be funded from funds generated in Australia. Massive Group continues to work collaboratively with the UK business on clients and services.

Andrew Fryatt, CEO, commented: 

"Since the original agreement in 2016, the management team of Massive Group have very successfully driven both revenue growth and EBITDA performance, building a strong foundation for the future business for the next few years. We are delighted to welcome them fully into the Group, and I know they are committed to continuing this record of growth, trading as Jaywing Australia."

This announcement is released by Jaywing and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Group by Andrew Fryatt, Chief Executive Officer.

 

Enquiries

Jaywing plc  ( www.jaywingplc.com )

Andrew Fryatt (CEO)

Tel: 0114 281 1200

 

Cenkos Securities plc

Nicholas Wells/Callum Davidson (Nominated Adviser)

Tel: 0207 397 8900

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGGCUUPUGAU
Date   Source Headline
13th Feb 20257:00 amRNSCancellation - Jaywing Plc
5th Feb 202510:39 amRNSResult of GM, Cancellation of Admission to Trading
21st Jan 20254:18 pmRNSCircular Amendment
14th Jan 20257:00 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSPublication of Circular and Notice of GM
23rd Dec 20243:02 pmRNSNotice of Requisition of General Meeting
19th Dec 20247:00 amRNSInterim Results
3rd Dec 20247:00 amRNSChange of Registered Office
7th Oct 20247:00 amRNSIncrease in Loan Facility
1st Oct 20247:00 amRNSTrading update and further funding
26th Sep 20242:42 pmRNSResult of AGM
4th Sep 20244:59 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSFinal Results
31st Jul 20241:58 pmRNSStatement regarding share price movement
21st Jun 202412:01 pmRNSUpdate on Loan Facility
28th May 20245:38 pmRNSIncrease in Loan Facility
13th May 20247:00 amRNSBoard, Trading Update, Strategic Review Conclusion
3rd Apr 202411:04 amRNSBoard Appointments
26th Mar 20241:57 pmRNSForm 8.3 - Jaywing PLC
18th Mar 20245:39 pmRNSForm 8.3 - Jaywing Plc
18th Mar 20245:31 pmRNSForm 8.3 - Jaywing plc
18th Mar 20242:02 pmRNSForm 8.3 - Jaywing plc
15th Mar 20244:45 pmRNSForm 8.3 - Jaywing Plc
15th Mar 20244:21 pmRNSForm 8.3 - Jaywing plc
14th Mar 20245:43 pmRNSForm 8.3 - Jaywing plc
14th Mar 20244:14 pmRNSForm 8.3 - Jaywing Plc
14th Mar 20241:53 pmRNSForm 8.3 - Jaywing PLC
7th Mar 20243:00 pmRNSForm 8
6th Mar 202411:09 amRNSForm 8.3 - Jaywing PLC
4th Mar 20243:56 pmRNSForm 8.3 - Jaywing plc
4th Mar 20249:25 amRNS2.9 Announcement
4th Mar 20247:00 amRNSTrading update, Loan Facility and Strategic Review
21st Dec 20237:00 amRNSHalf-year Report
20th Oct 20237:00 amRNSAppointment of Nominated Adviser and Broker
28th Sep 20234:28 pmRNSResult of AGM
7th Sep 20237:00 amRNSFinal Results
13th Apr 20237:00 amRNSGrant of Share Options
16th Feb 20237:00 amRNSTrading Update
14th Feb 202311:37 amRNSAIM Rule 17 Notification
5th Jan 20233:57 pmRNSHolding(s) in Company
1st Dec 20226:11 pmRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSHalf-year Report
11th Nov 202212:42 pmRNSHolding(s) in Company
8th Nov 20222:29 pmRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
29th Sep 20223:49 pmRNSResult of AGM
6th Sep 20222:01 pmRNSFinal Results
26th Aug 202211:59 amRNSAcquisition of Midisi Limited (replacement)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.